bf/NASDAQ:SRPT_icon.jpeg

NASDAQ:SRPT

Sarepta Therapeutics

  • Stock

USD

Last Close

17.64

06/11 22:33

Market Cap

14.11B

Beta: 1.02

Volume Today

1.25M

Avg: 1.51M

PE Ratio

−16.13

PFCF: −19.07

OverviewFinancialsAPI

    Description

    Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -4-3-2-12017-07-192019-08-072021-08-042023-08-022024-08-07

    Revenue (Estimate*)

    100M200M300M400M2017-07-192019-08-072021-08-042023-08-022024-08-07

    *Estimate based on analyst consensus